Ventrix Inc.

Grand Junction, CO

UEI
GZK6V6LL3SM8
CAGE
5DP40
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
322 Iron Horse Ct, Grand Junction, CO 81507, USA
Website
ventrixbio.com
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Pivotal preclinical studies of novel infusible ECM for treating acute MI R44HL169072 National Heart Lung and Blood Institute (NIH) $2,544,449
New infusible ECM hydrogel for treating acute myocardial infarction R43HL150917 National Heart Lung and Blood Institute (NIH) $791,543
Percutaneous deliverable biomaterial for treating myocardial infarction R43HL108459 National Institutes of Health $496,930
Phase II: percutaneous deliverable biomaterial for treating myocardial infarction R44HL108459 National Institutes of Health $2,059,825
Sbir phase i: feasibility of a minimally-invasive biomaterial therapy for heart failure 1014429 National Science Foundation $180,000

Quick answers

Is Ventrix Inc. registered in SAM.gov?

Yes. Ventrix Inc.'s SAM.gov registration is active through March 24, 2027.

What is Ventrix Inc.'s most recent federal award?

Ventrix Inc.'s most recent federal grant award is Pivotal preclinical studies of novel infusible ECM for treating acute MI (R44HL169072), from National Heart Lung and Blood Institute (NIH), on September 15, 2023.

On GovTribe

See Ventrix Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login